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There is a  rapidly growing body of evidence to establish the presence of immuno- 
globulins on the surface of lymphoid cells in mice (1-8). The classes of these immuno- 
globulins and their distribution, however, are still subjects of controversy. The immu- 
noglobulins detectable on spleen cells, for example, have been variously reported as 
being distributed among all of the major classes, IgM, IgG, and IgA (2, 3, 5), and as 
being confined primarily to IgM (4, 6, 9).  Some investigators (2, 3) have detected only 
a  single class of  heavy chain on any given cell, whereas others (5, 8) have presented 
evidence for possible multiple heavy chain classes on each cell. It is generally agreed 
that many peripheral lymphoid cells, such as those in the spleen, bear surface immuno- 
globulins. There is conflicting evidence, however, as to whether cells of  thymic origin 
are essentially lacking in these structures  (2,  6)  or bear them in  low but detectable 
numbers (3,  7,  10). 
Available evidence universally points to these surface immunoglobulins as products 
of the cells upon which they appear, and it is generally thought that these molecules 
all function somehow in antigen recognition. There is, however, some evidence that 
the antigen-binding or "receptor" function may actually be limited to IgM (4, 11, 12). 
Several approaches for determining the biological significance of these proteins have 
been based upon utilization of a wide selection of antisera directed against whole im- 
munoglobulins or their constituent chains. It has been shown, for example, that the 
plaque-forming response of immune cells cultured in vitro can be suppressed by treat- 
ment with antisera against whole gamma globulin, IgM, IgG, or K-light chains (13- 
16). It has also been reported that pretreatment of lymphoid cells  with  antibodies 
against gamma globulin can diminish the graft-vs.-host (GVH) 1 reaction when these 
cells are  injected into appropriate hosts  (17-19).  Similar pretreatment  experiments 
using various antisera of single chain specificity have demonstrated that suppression 
of the GVH reaction is possible only with anti-light chain (anti-K) antibodies (11) and 
that  adoptive antibody production can be prevented only with  anti-light chain or 
anti-/z antibodies (12). 
* This research was supported in part by US Public Health Service Training Grant 5-T01- 
AI00131-09 and US Public Health Service Grant AI 6552-07. 
1 Abbreviations used in this paper: BM, bone marrow; GVH, graft-vs.-host; LPS, lipopoly- 
saccharlde; PBS, phosphate-buffered  saline; T, thymus. 
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There  have been relatively few attempts to alter the immune responses of intact 
animals  with  anti-immunoglobulin  antisera.  Antibodies  against  human  myeloma 
lambda chains which cross-react with mouse kappa chains have been shown to inhibit 
the  synthesis of certain kappa determinants when injected into neonatal mice,  but 
over-all immunoglobulin levels were not affected (20). In chickens, the administration 
of anti-/z antibodies during embryonation together with bursectomy and  additional 
anti-~ at hatching has produced agammaglobulinemia (21), apparently by plasma cell 
line elimination (22). 
Our approach has been to treat neonatal  or young  adult mice with heterol- 
ogous  antisera  against  specific heavy  chains  and  then  assay  these  animals 
for suppressed immune  responses, both humoral  and cellular. We have previ- 
ously  reported  that  such  neonatal  treatment  of  mice  with  anti-/z  produces 
absolute suppression of IgM production, as reflected in serum immunoglobulin 
level and direct plaque formation, and severe reduction of all other serum im- 
munoglobulins (23). This agrees with the recent observation of a  lower number 
of antibody-forming cells in the spleen, lymph nodes, and gut of germfree mice 
treated  neonatally  with  anti-/z  (24).  We  have  since  reported  that  neither 
anti-# nor anti-~,l~,2 antisera are capable of altering the course of homograft 
rejection in mice, even in massive doses far in excess of those required to effect 
profound humoral suppression (25). We report here the extension of our studies 
to include mice treated initially as young adults and our investigations of the 
mechanism and extent of this type of suppression. 
Materials and Methods 
Animals.--BALB/c mice were used in all of these studies; for the target cell experiments, 
genetically thymusless  (nude) mice of the strain described by Pantelouris (26) were also used. 
Because these nude mice cannot suckle their young, they must be obtained by mating animals 
heterozygous  for the nude trait. The nude and phenotypically normal littermate progeny so 
derived were maintained on sterilized Purina 5010C feed (Ralston Purina Co., Inc., St. Louis, 
Mo.) and acidified-chlorinated water. BALB/c mice were weaned on day 24 and nude mice on 
day 30. 
Preparation of  Immunoglobulim.--IgM,  IgA,  and  IgG2  were  isolated from  the  sera 
of BALB/c mice bearing, respectively, the myeloma tumors MOPC-104E  (X/z), MOPC-406 
(~a), and MOPC-173D  (K'r2). IgG of both subclasses, IgG1,2 (KX~I'r2), was prepared from 
normal BALB/c serum. Purification of IgM and IgA was achieved  by successive treatments 
with Pevikon block electrophoresis,  gel filtration on columns of Sephadex G-200 (Pharmacia 
Fine Chemicals Inc., Rochester,  Minn.), and diethylaminoethyl (DEAE)-cellulose chromatog- 
raphy, using gradient elution (27). Purification of both types of IgG preparation included an 
initial  precipitation  step with ammonium sulfate (27), followed successively by treatments with 
DEAE-cellulose and Sephadex G-200. Purity of all preparations was checked by immunoelec- 
trophoresis developed with high titered anti-whole mouse serum and Ouchterlony gel diffusion 
developed with commercial  (Meloy Laboratories, Springfield, Va.)  class- or subclass-specific 
antisera. 
Preparation of Antlsera.--Antisera were  prepared by subcutaneous  injection of rabbits. 
Each animal received two weekly injections of 10-15 mg of purified immunoglobulin in com- 
plete Freund's adjuvant (Difco Laboratories, Detroit, Mich.) and four to six further weekly 
injections of 10-15 mg in incomplete Freund's adjuvant (Difco), until serum precipitin tlters 1318  IMMUNOSUPPRESSION  WITH  ANTI-IMMUNOGLOBULIN  ANTISERA 
ceased to rise. All antisera were routinely absorbed with BALB/c red blood cells,  mouse a- 
globulin (fraction IV, Pentex Biochemical, Kankakee, ILL), and mouse albumin (fraction V, 
Pentex), although specificities were generally lacking in the unabsorbed antisera. Light chain 
specificities were removed from the anti-IgM antiserum by absorption with IgA and IgG1,2. 
Similarly, anti-IgG1,2 antiserum was made ~,lv2-chain specific by  absorption with IgA and 
IgM. A portion of the anti--rl-r2 serum was further absorbed with IgG2, rendering it anti-71 
specific.  Absorptions with soluble proteins were made at 37°C for 1 hr, then overnight at 5°C, 
followed by centrifugation at 25,000  g for 30 min. Multiple absorptions were made until no 
further precipitate could be detected, resulting in a slight final excess of absorbing protein. The 
unabsorbed anti-IgG1,2, used for  facilitation of  indirect plaques,  showed no cross-reaction 
with IgM or IgA in immunoelectrophoresis. Specificity of all absorbed antisera was checked by 
immunoelectrophoresis and Ouchterlony gel diffusion using commercial (Meloy) class-specific 
antiserum standards. The only antiserum not showing complete heavy chain specificity by 
these tests was the anti--r1, which retained a slight trace of anti-v2 activity. Activities of anti- 
sera used were evaluated in Ouchterlony gel diffusion plates. The antisera used for suppression 
were capable of producing precipitin bands at dilutions of 1:64 (anti-/z) or 1:128 (anti-~/13,2 
and anti-y1) when reacted against normal or myeloma mouse sera diluted 1:4. 
Suppressive Treatment.--Each  litter of mice was divided between animals injected  intra- 
peritoneal]y with  anti-immunoglobulln serum  and  controls  similarly  injected with  normal 
rabbit serum. Neonatally treated animMs were injected with 0.05 ml on the day of birth (day 
0). The size of subsequent injections, given at 2- to 7-day intervals, was increased slowly until 
the total desired dose was achieved. At no time did a single injection exceed 0.35 ml. 
Immunization.--Specific  immunization was carried out byintraperitoneal injection of sheep 
erythrocytes which had been washed three times and resuspended in phosphate-buffered saline 
(PBS), pH 7.2. In the single experiment with nude mice and their littermates, immunization 
was accomplished by intravenous injection of 10/~g of lipopolysaccharide from Escherichia 
coli, strain 0113. 
Irradiation  and Reconstltutlon.--Young  (35-38-day-old) BALB/c mice to be reconstituted 
with thymus and/or bone marrow cells were given 900 rads of whole body cobalt irradiation. 
Syngeneic donor thymuses were removed into cold PBS and minced through 80-mesh stainless 
steel screens. The resulting single cell suspensions were washed once and resuspeuded in PBS. 
Bone marrow from the same donors was removed from the long bones of the hind legs into cold 
PBS, dispersed by gentle aspiration, washed once, and resuspended in PBS. Normal donors for 
the reconsititution of unirradiated, antibody-suppressed recipients were all 6-wk-old females. 
Normal and antibody-suppressed donors for the reconstitution of  irradiated  recipients were 
4-5 wk old and divided equally between males and femMes.  Reconstitution was accomplished 
intravenously. 
Immunological A ~says.--Antibody-forming  cells were enumerated using a slide modification 
of the Jerne plaque assay (28). The facilitating antiserum used for indirect plaques was unab- 
sorbed anti-IgG1,2; in  studies of yl suppression, plaques were also facilitated with specific 
anti-71 antiserum. The two facilitation antisera had identical precipitin activities and were 
used at the same predetermined optimal dilution (1 : 1000). The number of indirect plaques or 
-/1-specific  plaques was calculated as the difference between numbers of facilitated and direct 
plaques.  The response  to lipopolysaccharide was  measured as  a  plaque assay,  using sheep 
erythrocytes conjugated with this antigen (29).  A sheep erythrocyte background control was 
performed for each animal. 
Serum immonoglobulin levels were  determined semiquantitatively by the serial dilution 
Ouchterlony gel diffusion technique of Arnason et al.  (30).  These levels were reported as the 
reciprocal of the highest twofold serum dilution producing a distinct band against a constant 
dilution of commercial (Meloy) class-specific antiserum.  When undiluted serum produced  no 
reaction, a value of zero was assigned. Mean serum levels for groups were calculated as  simple 
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RESULTS 
Immunosuppression  of Neonatal  Mice with Anti-lz Serum.--We have previ- 
ously reported that mice injected for the 1st few days of life with rabbit anti- 
bodies against mouse /z-chains  develop an absolute loss  of ability to produce 
direct plaques against sheep erythrocytes, a complete loss of serum IgM, and 
severely depressed  levels  of all  other  serum  immunoglobulins (23).  Indirect 
plaque responses of controls to the single injection of sheep erythrocytes were 
not sufficient to evaluate the effect of anti-# treatment.  By administering a 
second  erythrocyte injection,  we have  now  been  able  to  demonstrate  that 
neonatal suppression with anti-# serum also completely eliminates the indirect 
plaque response (litters 1-3, Table I). 
Although the  absolute  elimination of both  direct  and indirect  plaque  re- 
sponses would suggest complete suppression of both IgM  and IgG antibody 
production, it is interesting to note that the only serum Ig which could con- 
sistently be depressed below detection limits was IgM. As shown in Table II, a 
short-term,  low dose regimen of suppression produced complete loss of IgM 
but relatively little effect on IgG levels (litter 4). A prolonged, high dose regi- 
men, on the other hand, resulted not only in the complete loss of IgM but also 
in the early reduction of all other serum immunoglobulins to very low residual 
levels. We initially believed that these early Ig residuals, at least for IgG, might 
represent declining levels of maternally derived antibody. A second assay on 
these heavily suppressed mice 3 wk later, however, revealed small but appre- 
ciable increases  in serum IgG1, IgG2,  and IgA. IgM remained undetectable 
throughout. 
Because the loss of serum IgM and inability to form plaques was absolute in 
neonatally treated mice, we next sought to determine if the effect was reversible, 
that is could these mice recover immunologically upon cessation of treatment. 
That they do in fact recover is illustrated by litter 5 (Tables I  and II). These 
mice, suppressed for the 1st 15 days of life, showed the usual serum pattern at 
day 24,  including the complete absence of IgM. They were allowed to coast 
until day 40,  at which time they were injected with 7.5  X  107 sheep erythro- 
cytes. Assay on day 46 revealed not only a direct plaque response fully as great 
as that of the controls but also serum IgM and IgG1 levels recovered to near 
control values. 
Immunosuppression  of  Young  Adult  Mice  with  Anti-#  Serum.-We  next 
attempted to determine whether the same type of severe immunosuppression 
produced in neonatally treated mice could be achieved by treatment of mice 
which had already reached the  age  of immunocompetence. Tables  I  and II 
present our findings for mice started on suppressive treatment at 21 days of age 
or older. Mice treated with a short-term, low dose schedule and immunized only 
once with a low dose of sheep cells  (7.5)<  107) did show a very severe (26- to 
33-fold)  depression in direct plaque-forming cells compared to controls (litters 
6  and 7).  Mice given identical suppressive treatment but immunized with a 1320  IMMUNOSIYPPRESSION  WITH  ANTI-IMMUNOGLOBULIN  ANTISERA 
larger  dose  of  sheep  cells  (15  X  107),  however,  showed  a  much  less  marked 
depression, dropping only three- to sixfold (litters 8 and 9). Increasing the sheep 
cell  dose  even  more  by  adininlstering  a  second large  injection  of  sheep  cells 
(15  X  10  7) made the relative direct plaque depression still less (two/old), even 
TABLE  I 
Suppression  of Plaque-Forming Cells  (PFC)  in Mice Injected with Rabbit Antiserum  against 
M ouse #-Chains 
Litter No.  Antiserum  1  ° SRBC  2  ° SRBC  As-  Mean direct  Mean indirect* 
(No. con-  PFC/spleen  PFC/spleen 
trois/treated)  injected  given  given  sayed  control/treated  control/treated 
~ay  ,~z  day  (,~)$~)x  day (!~g÷)x  day 
1  (2/4)  0-26  (0.35)  31  (7.5)  39  (7.5)  45  3100/0  15,200/0 
2  (2/2)  0-22  (0.42)  19  (7.5)  27  (7.5)  35  1200/0  2300/0 
3  (3/3)  0-52  (2.40)  42  (15)  55  (15)  62  800/0  1900/0 
4  (2/2)  0-9  (0.23)  18  (7.5)  24  7800/0 
5  (3/3)  0-15  (0.47)  40  (7.5)  46  17,000/25,400 
6  (3/3)  21-25  (0.40)  29  (7.5)  34  3300/100 
7  (3/3)  21-25  (0.40)  28  (7.5)  33  2600/100 
8  (3/3)  21-25  (0.40)  29  (15)  35  10,200/3100 
9  (3/3)  21-25  (0.40)  29  (15)  35  13,400/2200 
10  (3/3)  37-43  (0.70)  32  (15)  45  (15)  54  600/300  5200/600 
11  (2/3)  21-34  (1.00)  28  (15)  37  (15)  44  1000/600  3600/2700 
* Facilitated  with anti-G1,2  antiserum and calculated  as the difference between numbers 
of facilitated  and direct plaques. 
T?d3LE  II 
Suppression  of Serum Immunoglobulin Levds in Mice Injected ugtk Rabbit Antiserum 
Against  Mouse  ~-Chalns 
Litter No. 
(No.  Antiserum 
controls/  Injected 
treated 
day  ml 
3  (3/3)  0-52  (2.40) 
12  (2/2)  0-53  (2.40) 
4  (2/2)  0 9  (0.23) 
5  (3/3)  0-I5  (0.47) 
7  (3/3)  21-25  (0,40) 
9  (3/3)  21-25  (0.40) 
11  (2/3)  21  34  (1.00) 
IgM 
day 
(41)  32/0' 
(42)  32/0 
(24)  16/0 
(24)  27/0 
(33)  21/64 
(35)  32/64 
(44)  48/85 
Mean serum Ig level control/treated 
IgG1  ]  IgG2  IgA  IgG1 
850/19 
1024/16 
128/64 
256/32 
425/1365 
170/1365 
1024/2048 
IgG2 
32/2 
128/1 
64/64 
64/27 
8s/ss 
64/64 
64/64 
IgA 
12/0  (63) 
(46] 
IgM 
32/0 
32/0 
32/27 
1024/140 
1024/48 
256/150 
IgG2 
I 
128/7 
128/4 
170/'64 
11/11 
12/3 
* Numerical  average  of highest individual  reciprocal  serum dilutions producing  precipitin  bands  in Ouch- 
terlony gel  diffusion. 
though  the  suppressive  dose of  antiserum  was  about  doubled  and  extended  to 
include  a  treatment  between  sheep  cell injections  (litters  10  and  11).  Caution 
nlust be exercised, however,  in interpreting  the  direct  plaques  produced  in re- 
sponse to secondary immunization as due exclusively to IgM.  Indirect  plaques 
were also depressed,  but to varying  degrees. Note that in litter 10,  suppression DEAN  1).  MANNING  AND  JOHN  W.  JUTILA  1321 
was not started until 5 days after the first sheep cell injection, allowing a full 
primary  response  before  treatment  with  the  suppressive  antiserum.  It  was 
anticipated that in view of the antigen dosage effect just described, exposure 
to antigen before suppression should make the animals even more refractory, 
but such did not  appear to be the case.  This  antigen  dose dependence is  in 
striking  contrast  to  the  independence  of  antigen  dose  reported  earlier  for 
neonatally  suppressed  animals,  in  which  it  was  found  that  increasing  the 
antigen dose from 7.5  X  107 to 3.75  X  108 could not even partially overcome 
the suppressive effect (23). 
The serum levels  of mice receiving their first  anti-#  treatments  as  young 
FIG.  1.  Mouse serum proteins  (diffusing from outer wells at dilutions shown)  detectable 
by anti-# antiselum (center wells). (a) Serum dilutions from a mouse treated as a young adult 
with normal rabbit serum, showing a normal IgM level of 16. (b). Serum dilutions from a mouse 
similarly treated with anti-# antiserum, showing a  normal IgM level of 32  (outer bands) and 
an aberrant #-bearing protein level equal to or exceeding 256  (shown in a  second plate to be 
512). 
adults  (Table  II)  proved to  be  rather  surprising.  Despite  generally lowered 
plaque-forming  responses,  serum  levels  of  both  IgM  and  IgG1  rose,  some- 
times  strikingly,  rather  than  falling.  IgG2  levels  remained  constant,  never 
falling  as  they did in  neonatally treated  animals.  Even more surprising  was 
the  appearance  in  the  serum  of some substance  detectable  only with  anti-# 
antiserum of proven specificity (Meloy) but diffusing in Ouchterlony gel plates 
in an entirely different position from normal serum IgM. As seen in Fig. 1, this 
material,  diffusing from the outer wells,  formed a  precipitin band well inside 
that  of normal IgM,  suggesting  a  smaller molecule, such  as free #-chains  or 
perhaps a monomer of IgM. This substance, usually detectable in our Ouchter- 
lony assay system at serum dilutions of 1:128 to 1:512  (serum levels of 128- 
512),  was  frequently  completely  absent  in  control  animals  and  was  never 1322  IMMUNOSUPPRESSION  WITH  ANTI-IMMUNOGLOBULIN  ANTISERA 
detectable at dilutions above 1:4. The persistence of this material is illustrated 
by a litter of mice injected with 0.80 ml of anti-# between days 20 and 28  and 
assayed periodically thereafter. At day 34 the mean serum level was 181, falling 
to 43 by day 47, to 24 by day 60, and to 12 by day 74. The mean littermate 
control  level  (injected  with  an  identical  regimen  of  normal  rabbit  serum) 
remained at three throughout the period. 
Immunosuppression  of Neonatal Mice  with  Anti-yl  or Anti-'fly2  Serum.  - 
The data in Tables III  and IV show that suppression with antisera directed 
against IgG heavy chains characteristically produced less notable results than 
treatment with anti-# serum. Anti-~,ly2 administered in a very low dose, short- 
term regimen produced no apparent effect on either direct or indirect plaque 
responses to a single injection of sheep erythrocytes (litter 13). A slight increase 
in the total antiserum dosage and treatment time resulted in the elimination of 
the indirect response but produced no effect on the direct response (litter 14). 
A further great increase in the suppressive dose and prolongation of treatment 
to cover the period needed for a secondary response to sheep cells (litters 15- 
17)  confirmed the total elimination of the indirect plaque response.  In  these 
mice we also observed a  partial suppression of the direct plaque response but 
never eliminated it. 
Anti-~,l produced the same sort of complete or nearly complete suppression 
of the indirect plaque response as did anti-yl-/2 and about the same degree of 
inhibition  of direct plaque  formation  (litters  18  and  19).  In  fact,  dose  con- 
sidered,  it seemed somewhat more  effective, especially against  the  direct re- 
sponse.  In  control  animals,  facilitation with  anti-yl  produced half  to  two- 
thirds as many developed plaques as facilitation with  anti-IgG1,2  (litters  15, 
18,  and  19).  The higher  anti-IgG1,2  counts  presumably  represent  either  a 
difference in efficacy of the developing antisera or IgG2 plaques.  Note, how- 
ever,  that  anti-~,l  suppression  resulted  in  similar  degrees  of  reduction  in 
plaques  developed with either antiserum,  indicating that production of IgG2 
plaque-forming cells which might  occur was  also suppressed  by anti-71  anti- 
bodies. 
The effects of anti-71"r2 or anti-yl  antisera upon serum Ig levels were less 
marked than those  of anti-/,.  IgG2  and IgA  levels, for example, were rarely 
affected noticeably by anti-yl~,2, even by the largest doses and most prolonged 
treatments  (litters  13  17,  Table  IV).  Serum  IgG1,  on  the  other hand,  fre- 
quently demonstrated  a  noticeable early depression  (litters  13  17),  although 
at least a  partial  recovery occurred even during continued suppressive treat- 
ment  (litters  16  and  17).  In litters  16  and  17,  the two most heavily treated 
litters, IgM rose to levels 8- to 16-fold greater than controls. This is at variance 
with  our preliminary observation (23)  that larger doses of anti--/l~,2  did not 
seem to affect IgM levels as much as smaller doses. The most heavily treated 
mice  maintained  their  elevated IgM  levels  but  showed  no  evidence  of  any 
aberrant/z-containing protein such as that stimulated by anti-/, treatment of DEAN  D.  MANNING  AND  JOHN  W.  JUTILA  1323 
adults. The familiar pattern of a stable IgG2 level, a slight drop in IgG1 and a 
slight  rise  in  IgM  was  observed  in  animals  given  moderate  treatment  with 
anti-3,1. 
Because of the large anti-3,172  doses required to effect neonatal suppression 
and because  of the  partial  nature  of the suppression  of young adult  mice by 
anti-/z, suppression of adults was not attempted with anti-71~2 or anti-'rl. 
Determination  of  Immunosuppression  Target  Cells.--Antiserum  against 
/z-chains was selected for studies  of the target cells of the immunosuppressive 
effect reported here because among the antisera studied it consistently produced 
the  most severe  depressions  with  the  lowest  treatment  doses  and  times.  Our 
TABLE III 
Suppression  of Plaque-Forming Cells in Mice Injected with Rabbit Antiserum against Mouse 
71 or 71 y2-Chains 
Litter No. 
(No. con-  Antiserum 
trols/  injected 
treated) 
day  ml 
13  (3/3)  0-12  (0.55) 
14  (2/2)  0-15  (0.70) 
15  (3/3)  0-45  (1.50) 
16  (3/3)  0-55  (3.00) 
17  (3/4)  0-54  (3.00) 
18  (3/4)  0-25  (0.70) 
19  (3/3)  0-24  (0.55 
Anti- 
bodies 
lirecte{ 
againsl 
YlT2 
713,2 
ylT2 
T1T2 
3d'y2 
3"1 
"rl 
1  ° SRBC 
given 
16  (7.5) 
20  (7.5) 
1:0  (7.5) 
1:2  (15) 
1:2  (15) 
.q  (7.5) 
.~0  (7.5) 
2  ° SRBC 
:iven 
(No.  X 
a5  107) 
~7  (7.5) 
56  (15) 
~6  (15) 
~o  (7.5)1 
!9  (7.5)1 
Mean  Mean 
direct  indirect* 
As-  PFC/spleen  PFC/spleen 
;aye,  control/  control/ 
treated  treated 
day 
24  500/600  I  400/400 
30  1900/2100  1500/0 
53  1200/500  1200/0 
63  1000/300  3300/0 
63  2200/800  8500/0  I 
38  900/400  3600/200 
39  700/200  2900/0 
Mean "rl~ 
PFC/ 
spleen 
control/ 
treated 
600/0 
2300/200 
1800/0 
* Facilitated  with anti-G1, 2 antiserum  and calculated as the difference between numbers 
of facilitated  and direct plaques. 
3~ Facilitated  with  specific anti-T1 antiserum  and  calculated  as  the  difference between 
numbers of facilitated and direct plaques. 
first  effort  at  determining  the  target  of suppression  involved  an  attempt  to 
reconstitute  treated  animals  with  bone marrow  or thymus cells  from normal 
syngeneic animals.  A  litter  of animals was given a heavy suppressive  regimen 
(0.65 ml) over the 1st 27 days of life and allowed to coast for 5 days, at which 
time they were given either 5  X  107 normal bone marrow cells or 10  s normal 
thymus cells.  2 hr after intravenous  administration  of lymphoid cells,  all  ani- 
mals were given 15  X  107 sheep erythrocytes intraperitoneally.  5 days later the 
animals  were  assayed.  As  shown  in  Table  V,  immunosuppression  remained 
complete, with no plaque-forming cells detected and a  serum pattern identical 
to mice receiving no lymphoid cells. The effect was most likely attributable  to 
suppression of the donor cells by residual antiserum in circulation. 
Our  next  experiment  designed  to  determine  the  target  of suppression  em- 
ployed genetically  thymusless  mice.  These  mice have  been  shown  to  possess 1324  IM~fUNOSIYPPRESSION  WITI-I  ANTI-IMMUNOGLOBULIN  ANTISERA 
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an embryonic abnormal thymic rudiment which never becomes populated with 
lymphoid cells (31). Although unable to respond normally to thymus-dependent 
antigens such as sheep erythrocytes (32,  33); these mice have been shown by 
our colleagues, Manning et al. (34), to respond well to the thymus independent 
lipopolysaccharide (LPS) antigen of E. coll. 
Using this assay system, we attempted anti-/* suppression of thymusless mice. 
This experiment, presented in Table VI, provides definitive evidence that  at 
least part of the target cells of anti-/* suppression are of bone marrow origin. 
Thymusless control animals, treated only with normal rabbit serum, responded 
to LPS about as well as their phenotypically normal littermates and showed 
TABLE V 
Attempted Reconstitution of Anti-# Suppressed Mice with Cells from  Normal Bone Marrow 
or Thymus 
Reconstitution  Direct  Indirect  Mean serum 
Litter No.  Antiserum  SRBC  No. and type  PFC/  PFC/  Ig level 
(No. ani-  injected  given  Assayed  of cells 
mals)  (day 32)  spleen  spleen  IgM  IgG1  IgG2 
day  ml  day (Nj~)~)X  day 
20  (2)  048  (1.25)  54  (15)  59  None  0  0  0  128  8 
21  (2)  0-27 (0.65)  32  (15)  37  5 X  l0  T  BM*  0  0  0  64  8 
21  (2)  0-27 (0.65)  32  (15)  37  10ST~  0  0  0  48  6 
* Bone marrow cells. 
Thymus  cells. 
serum Ig levels comparable in all respects to normal animals except for a lower 
IgG1 value. Thymusless mice receiving anti-# antiserum, however, showed the 
complete elimination of plaque response typical of anti-/* suppressed animals 
and exhibited an even greater degree of serum Ig suppression than their pheno- 
typically normal littermates. Although these data clearly indicate suppression 
of  bone  marrow-derived  cells,  they  tell  nothing  about  the  possibility  that 
thymus-derived cells might also be affected. 
To try to answer the question of suppression of thymus-derived cells, a group 
of young adult mice was lethally irradiated (900 rads)  and reconstituted with 
various combinations of bone marrow (BM) and thymus (T) cells from normal 
and heavily anti-# suppressed (0.70 ml, 28 days) mice. These results are pre- 
sented in Table VII. As expected, mice receiving antigen only or antigen plus a 
single cell type, either BM or T, from normal mice made virtually no response. 
All  combinations of both  BM and  T  cells from either normal  or suppressed 
donors,  however,  made  similar,  fully reconstituted responses.  Whatever cell 
types may be affected in the intact suppressed animal, it is clear that both BM 
and  T  cells,  once removed from the suppressed  animals  and  placed into  an 1326  IMMUNOSUPPRESSION  WITH  ANTI-IMMUNOGLOBULIN  ANTISERA 
TABLE  VI 
Suppression  of Genetically Thymusless  (Nude) Mice with Rabbit Antiserum 
against Mouse Iz-Chains 
Type of mice  Type of  10 t*g  Mean  Mean Serum Ig level 
serum  LPS~:  Assayed  plaque~ 
(No.)*  injected  given  response  IgM  IgG1  IgG2  IgA 
ml  day  day 
Littermate nor-  Normal rabbit  (0.90)  31  35  4400  64  850  43  3 
mal (3) 
Littermate nor-  Anfi-/z  (0.90)  31  35  0  0  320  16  0 
mal (2) 
Thymusless (4)  Normal rabbit  (0.90)  31  35  5700  64  40  32  2 
Thymusless (3)  Anti-/z  (0.90)  31  35  0  0  5  1  0 
* Pooled from two litters. 
:~ Response to LPS  determined by plaque assay using sheep cells conjugated with LPS. 
TABLE  VII 
Reconstitution of Lethally  (900 fads)  Irradiated  Mice with  Bone Marrow  and  Thymus Cells 
from Normal and Anti-g Suppressed Donors 
No. of cells used in reconstltution 
No.* ot  Anti-~  Mean direct 
animals  Normal bone  Normal thymus  suppressedJ;  Anti-~ suppressed:~  plaques/spleen§ 
marrow  bone marrow  thymus 
2  ....  0 
2  --  2  X  108  --  --  0 
2  2  X  107  --  --  --  100 
3  2  X  107  2  X  10 s  --  --  2900 
3  2  X  107  --  --  2  X  10 s  1400 
2  --  2  X  l0 s  2  X  107  --  3100 
2  --  --  2  X  107  2  X  10 s  2000 
* Pooled from four litters, each litter being distributed equally among test groups. 
:~ Anti-# suppressed donors were treated from day 0-28 with a  total of 0.70 nal;  the ani- 
mals were sacrificed on day 29. 
§ All  animals were given  15  N  107  sheep  erythrocytes intraperitoneally on  the day  of 
reconstitution and assayed 9 days later. 
environment  free  of  anti-#  antibodies,  are  fully  capable  of  restoring  immune 
competence. 
DISCUSSION 
Our  data  indicate that  the injection of neonatal  mice with rabbit  antiserum 
directed  against  mouse  ~-chains  completely  prevents  these  animals  from  de- 
veloping  direct  or  indirect  plaque-forming  cells  to  sheep  erythrocytes.  This 
inability to form plaques is accompanied by the total loss of detectable  serum 
IgM  and,  if the  treatment  is continued for several  weeks,  by severe  decreases DEAN  D.  MANNING  AND  JOHN  W.  JUTILA  1327 
in serum levels of IgG1, IgG2, and IgA. The depression in serum IgG1 and IgG2 
does  not  become  fully apparent  until  sometime shortly after weaning,  pre- 
sumably because of the presence of maternal antibody Ig obtained by nursing. 
Despite the loss of ability to respond to at least certain specific immunogens and 
nearly complete loss of serum immunoglobulins, there was no indication what- 
soever at any time of wasting or loss of vigor among treated animals. 
The suppression of more than one Ig class in mice treated with anti-# serum, 
as observed by us and by Lawton et al. (24), is in accord with the dual IgM and 
IgG agammaglobulinemia achieved by Kincade et al. (21) with anti-# treatment 
of chickens. This progressive suppression of all classes  of serum Ig in mice by 
anti-# serum suggests that the production of all of these proteins depends upon 
cells bearing #-chains on their surfaces. There are several plausible variations of 
this  interpretation.  First,  some  nonproducing  cell  involved in  the  immune 
response, such as the macrophage or thymocyte, might be/z-bearing. Alterna- 
tively,  all  mature  lymphoid  cells  which  actually  produce  antibody  could 
possess surface/z-chains. This would agree with the observation of Vitetta et al. 
(4) that/z-chains compose some 90-95 % of the total heavy chains recoverable 
from the surface of mouse splenic lymphocytes. Such an interpretation would 
also be  consistent with the  finding by Bankhurst  and Warner  (5)  that  the 
number of mouse spleen cells detectable with radiolabeled anti-/~ antibodies is 
as great as the number detectable with labeled anti-K, the latter  representing 
the total number of cells bearing any surface Ig. 
Another alternative is the occurrence of/z-bearing precursors for all antibody- 
forming  cells.  This  interpretation  implies that  all  immunoglobulin-forming 
cell  lines possess/z-containing receptors in their early stages of development, 
making them susceptible  to  suppression,  but  during subsequent maturation 
may lose all or part of these receptors. They could, during maturation, retain 
or even add surface immunoglobulins of other classes.  Such a universal role for 
a/z-containing receptor is supported by the work of Warner et al.  (12),  who 
found that among a battery of antisera directed against heavy and light chains, 
only anti-~ and anti-/z could prevent antigen binding by splenocytes or  sup- 
press antibody production by treated cells when adoptively transferred. Simi- 
larly, Greaves  (35) has established that in the early stages of an immune re- 
sponse to sheep erythrocytes many antigen-binding cells bear multiple heavy 
chains but later usually become heavy chain class "restricted." Significantly, 
he found that in the early stages rosette formation by almost all cells can be 
blocked by anti-IgM but later many can be blocked only by anti-IgG sera. 
The related concept of an actual switch from IgM production to IgG produc- 
tion, as suggested by the presence of double producers, has been discussed at 
some length by Nossal et al. (36). 
Our  data  most  nearly support  this  latter  concept  of  early  possession  of 
/z-containing receptors and subsequent partial or complete loss or replacement 
during maturation. This support is based partly upon the draxnatic suppressive 1328  II~IMUNOSUPPRESSION  WITH  ANTI-IMMUNOGLOBULIN  ANTISERA 
effect of antl-/~  on all serum immunoglobulin levels in neonatally treated ani- 
mals as contrasted to the relatively minor influence on animals first treated as 
adults.  The failure of anti-#  treatment to ever completely suppress  IgG1  or 
IgG2 may be due to early (prenatal) maturation of a  few cells in  these lines 
with the consequent loss of #-bearing receptors. The partial recovery of serum 
IgG1 and IgG2 levels which we observed even among animals given continuous, 
massive anti-# treatment well into adulthood could then be due to the further 
development of these early maturing cells. 
That  such  differentiation can  in  some  cases  occur even during  continued 
suppression is  best  illustrated by the  changes in IgA  serum levels which we 
observed. Neonatal treatment with anti-/z serum consistently depressed serum 
IgA far below normal, frequently to undetectable levels. Even during continu- 
ous  treatment,  however,  IgA  levels  invariably  recovered,  often  to  normal 
values. If, as Walters and Wigzell (37) have suggested, surface immunoglobulins 
of lymphocytes involved in humoral  antibody production represent the pro- 
ductive potential of the cell,  then the IgM line might be expected to bear no 
surface immunoglobulins other than  those containing #.  This would account 
for the absolute suppression achieved in neonates and failure of IgM levels to 
recover during treatment. 
The difficulty of suppressing young adult animals with anti-# may in part be 
explained by their larger size and the presence of greater amounts of serum IgM. 
Both would make it difficult to achieve, with the small doses used, an adequate 
circulating concentration of unreacted anti-/x antibodies.  Perhaps  even more 
importantly, maturation of cell lines other than IgM could, in the view of our 
working hypothesis, lead to the loss of surface IgM receptors and thus to loss 
of susceptibility to anti-# suppression. 
There may be some cells of the IgM line which instead of being inactivated by 
anti-#  are triggered to production of some sort of nonantibody, unassembled 
IgM product. This would account for the soaring levels of aberrant #-containing 
protein  observed  in  animals  first  treated  as  adults.  The  decline  in  indirect 
plaques  but  rising  levels  of IgG1  suggests  a  similar,  but  lesser,  stimulatory 
activity of anti-# serum on the IgG1 line. 
Some support for the concept of changing surface immunoglobulins during 
cell line maturation can be gained from observations of the suppressive effects 
of anti-~,l~,2  and anti--~l. A low dose, early treatment was seen to produce little 
or no effect on plaque responses, whereas higher doses and prolonged treatment 
seemed to result in elimination of the indirect response and diminished serum 
IgG1.  This is  consistent with the idea that surface ~l-bearing structures be- 
come more abundant during maturation. The continued absence of an indirect 
plaque response accompanying the partial recovery of serum IgG1 levels during 
prolonged anti-~,l'r2  treatment suggests  the possibility that the  protein pro- 
duced during  "recovery" is  a  nonantibody Ig such  as the aberrant  ~-protein 
stimulated by  anti-# treatment  of young adults.  The significance of the ele- DEAN  D.  MANNING  AND  JOHN  W.  JUTILA  1329 
vated IgM levels in animals neonatally treated with anti-~,l~2 is not clear. It 
does not seem to be entirely analogous to the stimulatory effect of anti-# be- 
cause the aberrant/z-protein was never detected. How much of the IgG1 serum 
fluctuation is attributable to simple antigen-antibody complexing and clearance 
is not certain. 
The apparent suppression of IgG2 plaque-forming cells by anti-~,l might be 
explained by the known residual of anti-~,2  activity in this antiserum. It could 
also be explained by the report of Lee et al.  (8)  that among all mouse spleen 
cells showing any IgG determinants, nearly all have ~1 specificity, about two- 
thirds also have ~2 specificity, and only a very few have ~,2 specificity only. 
We consider the most likely explanation of the partial suppressive effect of 
anti--~l~,2  and anti-~l on the direct plaque response as being due to trace con- 
tamination with  anti-#.  Although  not detected by immunoelectrophoresis or 
Ouchterlony gel diffusion, such a contaminant might be detectable by the more 
sensitive radioimmunoprecipitation test  recommended by Nossal  et  al.  (36). 
In view of the massive doses of anti-~172  and anti-~,l  used and  the extreme 
suppressive  efficiency of  anti-/z  in  neonatal  animals,  even  an  undetectable 
trace contamination of anti-/z could account for this effect. 
The steady serum IgG2 levels observed constitute the most difficult aspect 
of the study to explain. Only massive neonatal treatment with anti-/~  appre- 
ciably affected IgG2 levels. Neither adult treatment with anti-# nor neonatal 
treatment with either anti-~l or anti-~,l~,2  moved these levels at  all,  although 
the  latter  antiserum  had  an  extremely high  precipitin  activity  against  ~,2. 
The complete elimination of indirect plaque formation by neonatal treatment 
with  either anti-/z or anti-~,l-y2  establishes  that  either IgG2  plaques  are not 
formed in response to sheep erythrocytes or else the IgG2 line is susceptible to 
suppression.  It  is  not  immediately apparent  why serum  IgG2  levels  should 
remain so constant. 
Our success in suppressing  genetically thymusless mice with  anti-#  serum 
clearly indicates that at least some of the target cells in the type of suppression 
reported here are bone marrow derived. We have no information bearing on the 
question of suppression of thymus-derived cells involved in humoral antibody 
responses other than the indirect evidence afforded by the homograft studies 
reported previously (25). In that case we found absolutely no evidence of pro- 
longation of survival of homografted skin resulting from the use of either anti-/z 
or anti-~,l~,2,  even when the grafted animals were massively treated  from the 
day of birth on through the entire rejection period. It is apparent,  therefore, 
that the population of thymus cells responsible for cellular immune responses 
(38-40) is not noticeably affected by these antisera. 
Our evidence indicating that the target cells of anti-/z antibodies in vivo are 
bone marrow derived agrees with the conclusion of Doria et al.  (41)  that the 
cells inhibited by exposure of mouse splenocyte cultures  to  anti-whole mouse 
serum were of nonthymic origin. It is an interesting contrast, however, to the 1330  IMA{UNOSUPPRESSION  WITH  ANTI-IMMUNOGLOBULIN ANTISERA 
finding  by Lesley et al.  (42)  that  the primary target of anti-light  chain anti- 
bodies (anti-K) in vitro is the thymus-derived cell. 
There  is  nothing  in  our  study  upon  which  a  mechanism can  be  based  to 
explain the actual suppressive effect of antisera on immune cells.  We have no 
basis for deciding  whether  cells contacting  antibody are reversibly inhibited, 
irreversibly inhibited,  or killed outright. Both the natural recovery of immune 
competence,  occurring  between  9  and  31  days  after cessation  of suppressive 
treatment, and the reconstitution of irradiated animals with thymus and bone 
marrow  cells  from  anti-#  suppressed  mice suggest  that  either  suppression  is 
reversible or the cells within the bone marrow and/or thymus  are not affected 
by antibody. Basten et al.  (10)  have demonstrated that  bone marrow-derived 
cells  are susceptible  to lethally  radioactive  antigen  only  when peripheralized 
to the spleen, indicating that while still in the bone marrow the cells are either 
inaccessible to the antigen or lack receptors for it. We believe that this sort  of 
cellular  inaccessibility  and/or  lack  of  differentiated  receptors  offer plausible 
support for the idea that cells within the marrow remain unaffected by anti-~, 
thus  explaining both  natural  recovery and  the  ability of these  cells  to  effect 
reconstitution  of irradiated animals. 
SUMMARY 
Neonatal injection of mice with rabbit anti-/z antiserum has been shown to 
produce complete loss of direct and indirect plaque-forming responses to sheep 
erythrocytes as well as loss of serum IgM and severe depressions of all  other 
serum immunoglobulins.  Similar  injection  of anti-~l~2  or  anti-'rl  antibodies 
effects a loss of the indirect response but induces relatively minor alterations in 
serum Ig levels. Delaying initiation of anti-/~ treatment until young  adulthood 
results  in  a  somewhat  diminished  effect  on  plaque-forming  responses  and 
serum Ig levels but  triggers  the  release  of high  serum  levels  of an  aberrant 
#-bearing  protein. 
Anti-# suppression of genetically thymusless mice indicates that at least part 
of the target cells for suppression are bone marrow derived. A working hypothe- 
sis for the maturation of humoral antibody-producing cell lines as it relates to 
these data is discussed. 
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